Back to Search Start Over

Synthetic mimetics assigned a major role to IFNAR2 in type I interferon signaling.

Authors :
Zoellner N
Coesfeld N
De Vos FH
Denter J
Xu HC
Zimmer E
Knebel B
Al-Hasani H
Mossner S
Lang PA
Floss DM
Scheller J
Source :
Frontiers in microbiology [Front Microbiol] 2022 Sep 02; Vol. 13, pp. 947169. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).
Publication Year :
2022

Abstract

Type I interferons (IFNs) are potent inhibitors of viral replication. Here, we reformatted the natural murine and human type I interferon-α/β receptors IFNAR1 and IFNAR2 into fully synthetic biological switches. The transmembrane and intracellular domains of natural IFNAR1 and IFNAR2 were conserved, whereas the extracellular domains were exchanged by nanobodies directed against the fluorescent proteins Green fluorescent protein (GFP) and mCherry. Using this approach, multimeric single-binding GFP-mCherry ligands induced synthetic IFNAR1/IFNAR2 receptor complexes and initiated STAT1/2 mediated signal transduction via Jak1 and Tyk2. Homodimeric GFP and mCherry ligands showed that IFNAR2 but not IFNAR1 homodimers were sufficient to induce STAT1/2 signaling. Transcriptome analysis revealed that synthetic murine type I IFN signaling was highly comparable to IFNα4 signaling. Moreover, replication of vesicular stomatitis virus (VSV) in a cell culture-based viral infection model using MC57 cells was significantly inhibited after stimulation with synthetic ligands. Using intracellular deletion variants and point mutations, Y510 and Y335 in murine IFNAR2 were verified as unique phosphorylation sites for STAT1/2 activation, whereas the other tyrosine residues in IFNAR1 and IFNAR2 were not involved in STAT1/2 phosphorylation. Comparative analysis of synthetic human IFNARs supports this finding. In summary, our data showed that synthetic type I IFN signal transduction is originating from IFNAR2 rather than IFNAR1.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Zoellner, Coesfeld, De Vos, Denter, Xu, Zimmer, Knebel, Al-Hasani, Mossner, Lang, Floss and Scheller.)

Details

Language :
English
ISSN :
1664-302X
Volume :
13
Database :
MEDLINE
Journal :
Frontiers in microbiology
Publication Type :
Academic Journal
Accession number :
36118237
Full Text :
https://doi.org/10.3389/fmicb.2022.947169